Bone Biologics Corp. -CW26BBLGWPreferred / convertible
13F holders, Q4 2025 (December 31)2holders −1
0new positions
1sold out
1famous investor
$15.45avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Bone Biologics Corp. -CW26 (BBLGW) in their 13F filings, down 1 from Q3 2025. 0 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($548K) and UBS Group AG ($3K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bone Biologics Corp. -CW26
- CUSIP
- 098070154
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $800 |
All 13F filers, Q3 2025 → Q4 2025: 157 shares bought and 350 shares sold, net −193 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Citadel Advisors | — | Reduce -0.7% | 35,323 | $548K |
| UBS Group AG | — | Add +109.8% | 300 | $3K |
"% of holder's portfolio" is BBLGW's weight in each manager's 13F, not the share of Bone Biologics Corp. -CW26 the manager owns.